Overview
Ventas is a real estate investment trust (REIT) that holds a highly diversified portfolio of senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities throughout North America, and the UK. Ventas's portfolio of roughly 1,400 properties is buoyed by the demographic tailwind of a large and growing aging population. The company has a third-party institutional capital management business, Ventas Investment
...
Read More Management (VIM), which includes its open-ended investment vehicle, the Ventas Life Science & Healthcare Real Estate Fund (the Ventas Fund). The US generates the most revenue with nearly 90% of the company's total revenue.
Read Less
Read More Management (VIM), which includes its open-ended investment vehicle, the Ventas Life Science & Healthcare Real Estate Fund (the Ventas Fund). The US generates the most revenue with nearly 90% of the company's total revenue.
Read Less
#
678
Fortune 1000 Revenue Rank
Debra A Cafaro
See more contacts
Lessors of Real Estate
,
Real Estate
,
Real Estate and Rental and Leasing
,
Real estate investment trusts
Activities Related to Real Estate
,
Automotive Equipment Rental and Leasing
,
Commercial and Industrial Machinery and Equipment Rental and Leasing
,
Consumer Goods Rental
,
General Rental Centers
,
Lessors of Nonfinancial Intangible Assets (except Copyrighted Works)
,
Offices of Real Estate Agents and Brokers
?
?
?
Modelled
?
Actual
$4.92 billion
Actual
9.48%
$26,186
DEC
?
?
NYSE:VTR
Contacts
Get in Touch with 5 Principals* and 260 Contacts
-
Debra A CafaroChairman of the Board and Chief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$4.92 billion
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $1,330 | $1,120 | $1,120 |
| Net Investing Cash | -$2,377 | -$185 | -$859 |
| Net Financing Cash | $1,445 | -$544 | -$284 |
| Net Change in Cash | $398 | $391 | -$23 |
| Cash at Beginning of Period | $563 | $171 | $197 |
| Cash at End of Period | $957 | $563 | $171 |
| Capital Expenditure | -$604 | -$643 | -$454 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $898 | $509 | $123 |
| Accounts Receivable | $203 | $194 | $188 |
| Inventories | $ | $ | $ |
| Other Current Assets | $251 | $165 | $654 |
| Asset Summary | |||
| Total Current Assets | $1,352 | $868 | $965 |
| Tangible Fixed Assets | $ | $ | $ |
| Intangible Assets | $12 | $6 | $6 |
| Total Assets | $26,187 | $24,725 | $24,158 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $1,152 | $1,042 | $1,032 |
| Short-Term Debt | $6 | $14 | $428 |
| Other Current Liabilities | $146 | $127 | $117 |
| Liability Summary | |||
| Total Current Liabilities | $1,305 | $1,182 | $1,577 |
| Long-Term Debt | $13,516 | $13,477 | $11,869 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $15,357 | $15,181 | $13,936 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $109 | $101 | $100 |
| Retained Earnings | $ | $ | $ |
| Equity Summary | |||
| Total Equity | $10,771 | $9,488 | $10,153 |
| Shares Outstanding | 437,081,000 | 402,101,000 | 399,697,000 |